Article

Why Docs Won't Take Sick Time

Author(s):

Just in time for flu season, a California study shows that physicians are all too willing to work while they themselves are ill.

Physicians are notoriously prone to continue working while they are ill—even if what they have is contagious. Researchers at the University of California Irvine, Orange, CA surveyed physicians and medical students to see how extensive the phenomenon is at their academic medical center.

Reporting at IDWeek 2015, Kimberly Truong, MD, MPH, and colleagues reported their findings.

The team administered an electronic survey to 784 physicians and medical students and 474 responded. Nearly all (96.4%) said they would work if they had a cold; most (77.6%) said diarrhea would not keep them from working; over half (53.6%) said vomiting would not stop them from coming in and more than a third (36.3%) said even with a confirmed case of influenza they would report to work.

A low fever (up to 100.9 degrees F) was not reason to stay home, most (84.3%) said. Nearly a quarter (24.3%) said they would work even with a fever over 103 degrees F. Medical residents were most likely to work if they had the flu (35.5%) and attendings the least likely (9.1%)

Determination to report to work when sick was highest among emergency medicine and surgical departments.

The reasons they gave were that they felt guilty making colleagues cover for them, they didn’t believe their illness was sufficiently contagious, and that they didn’t feel sick enough to stay home.

What would it take for these ailing physicians and students to stay home? The top responses were that they would do that if a department chief set an action protocol for what to do when ill, if they saw colleagues get sent home for working when they were sick, and if they saw there were no negative repercussions to taking a sick day.

“Fixed protocols and supportive culture to prevent contagious spread can positively influence physician willingness to stay home if ill,” the researchers concluded.

Related Videos
Ladan Zand, MD: Evaluating Obinutuzumab in Primary FSGS and Further Research
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Kishore Iyer, MD , MBBS | Credit: Kishore Iyer on LinkedIn
Evan Dellon, MD, MPH | Credit: UNC Chapel Hill
Marlyn Mayo, MD | Credit: ACG
Kishore Iyer, MD, MBBS | Credit: Kishore Iyer on LinkedIn
Linda Stein Gold, MD: Discussing New Phase 3b Data on Lebrikizumab for Atopic Dermatitis
Bruce Sands, MD | Credit: Alimentiv
Andrea Murina, MD: Drug Pipeline for Hidradenitis Suppurativa
Quan Dong Nguyen, MD: Phase 2 Neptune Trial Advances Brepocitnib for Uveitis | Image Credit: Stanford University
© 2024 MJH Life Sciences

All rights reserved.